Pazaitou-Panayiotou et al. concluded that the ratios of IGF-1 to adiponectin and IGF-1 (adiponectin × IGF-binding protein 3 (IGF-BP3)) were positively associated with the tumor size in thyroid cancer patients [25]. Here, IGFBP3 is linked to neoplasm.